Beranda » Blog » Medidata Launches Clinical Data Studio, Leveraging AI to Modernize Data Experience in Clinical Trials

Medidata Launches Clinical Data Studio, Leveraging AI to Modernize Data Experience in Clinical Trials

Diposting pada 19 Juni 2024 oleh admin / Dilihat: 0 kali

Delivers data review and reconciliation activities with embedded AI up to 80 percent faster, simplifying the data lifecycle by connecting multiple data sources

New York–(ANTARA/Business Wire)– Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced the launch of Medidata Clinical Data Studio, a unified experience that reveals the true power of Medidata Clinical Data Studio. clinical research data. This innovative technology gives stakeholders greater control over data quality and the ability to deliver safer trials to patients faster.

Built on the Medidata Platform, Clinical Data Studio integrates data from Medidata and non-Medidata sources, accelerating decision-making across the full clinical trial process and providing holistic data and risk strategies that connect patients, sites and sponsors. Through AI, research teams can identify potential data issues and safety signals more effectively, resulting in a more accurate understanding of patients. This reduces the challenges posed by closed data systems and enables action data review and reconciliation up to 80 percent faster.

“Clinical Data Studio opens up a vast clinical data ecosystem. Powered by embedded AI, we democratize access to data and uncover the signals, risks and insights that matter most. This simultaneously accelerates trial execution and creates rich data for new discoveries,” said Tom Doyle, chief technology officer, Medidata.

Clinical Data Studio offers a comprehensive workspace for data integration, transformation, and management. This includes AI-assisted data reconciliation and anomaly detection, self-service data registers, robust risk-based quality management, and tools for implementing holistic data and risk strategies supported by workflows and visualization.

“As data volumes and sources grow exponentially, real-time data management and insight gathering become increasingly complex. “This not only impacts time to market, but also delays the timely delivery of therapy to patients, thereby impacting patients’ lives,” said Dr. Nimita Limaye, research vice president, Life Sciences Research and Development Strategy and Technology, IDC. “By enabling users to manage all their data, both Medidata and non-Medidata data, in one place, Medidata Clinical Data Studio has the potential to disrupt the industry by speeding up clinical trials and getting therapies to patients faster.”

About Medidata

Medidata supports smarter medicine and healthier communities through digital solutions to support clinical trials. Celebrating 25 years of breakthrough technology innovation across more than 33,000 trials and 10 million patients, Medidata offers industry-leading expertise, analytics-powered insights, and the world’s largest collection of patient-level historical clinical trial data. More than 1 million registered users across more than 2,200 customers trust Medidata’s seamless, comprehensive platform to improve the patient experience, accelerate clinical breakthroughs, and bring therapies to market faster. A Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) brand, Medidata is headquartered in New York City and has been recognized as a Leader by Everest Group and IDC. Find out more at www.medidata.com and follow us @Medidata.

About Dassault Systems

Dassault Systèmes is a catalyst for human progress. We provide a collaborative virtual environment for businesses and society to envision sustainable innovation. By creating virtual twin experiences in the real world using our 3DEXPERIENCE platform and applications, our customers can redefine the creation, production and lifecycle management processes of their offerings and thereby have a meaningful impact on making the world more sustainable. The advantage of the Experience Economy is that it is a people-centered economy that provides benefits to all parties – consumers, patients and citizens. Dassault Systèmes delivers value to more than 350,000 customers of all sizes, in all industries, in more than 150 countries. For more information, visit www.3ds.com

© Dassault Systems. All rights reserved. 3DEXPERIENCE, 3DS logo, Compass icon, IFWE, 3DEXCITE, 3DVIA, BIOVIA, CATIA, CENTRIC PLM, DELMIA, ENOVIA, GEOVIA, MEDIDATA, NETVIBES, OUTSCALE, SIMULIA and SOLIDWORKS are commercial trademarks or registered trademarks of Dassault Systèmes, a European company company (Societas Europaea) established under French law, and registered on the Versailles trade and company registry under number 322 306 440, or its subsidiaries in the United States and/or other countries. All other trademarks are owned by their respective owners. Use of trademarks of Dassault Systemes or its subsidiaries must be subject to their written approval.

Contact

Mediadata Public Relations

Analyst Relations

Source: Medidata

Reporter: PR Wire
Editor: PR Wire
Copyright © ANTARA 2024

Bagikan ke

Medidata Launches Clinical Data Studio, Leveraging AI to Modernize Data Experience in Clinical Trials

Saat ini belum tersedia komentar.

Mohon maaf, form komentar dinonaktifkan pada halaman/artikel ini.

Medidata Launches Clinical Data Studio, Leveraging AI to Modernize Data Experience in Clinical Trials

Chat via Whatsapp

Ada yang ditanyakan?
Klik untuk chat dengan customer support kami

Iffah
● online
Iffah
● online
Halo, perkenalkan saya Iffah
baru saja
Ada yang bisa saya bantu?
baru saja

Produk yang sangat tepat, pilihan bagus..!

Berhasil ditambahkan ke keranjang belanja
Lanjut Belanja
Checkout
Produk Quick Order

Pemesanan dapat langsung menghubungi kontak dibawah: